Breast cancer comes in many forms—it’s not the same for everyone. The disease varies a lot based on biology and molecular markers.
HER2-positive breast cancer is one of the most aggressive types, but doctors can treat it well.
If you or someone you care about has gotten a diagnosis that mentions HER2 status, knowing what that means can help you make better choices about treatment.
In this blog, we’ll look at what HER2-positive breast cancer is, how it differs from other types like HER2-negative breast cancer, what tests doctors use, and treatment options for HER2-positive breast cancer.
What is HER2?
The Role of HER2 in Cell Growth
HER2 means human epidermal growth factor receptor 2, a protein on the outside of breast cells. It helps normal cells grow. However, in some breast cancers, there’s an excessive amount of the HER2 gene, resulting in the overproduction of HER2 protein.
This causes cells to divide, and without control, it is a key sign of HER2-positive breast cancer.
How Too Much HER2 Protein Can Cause Cancer
When there’s too much HER2 protein, it can lead to cancer growth. This increased expression doesn’t come from genetics but develops as the cancer forms. The amount of HER2 in a tumor helps doctors determine if targeted treatment will be effective.
HER2 amplification enables the cancer to grow faster, but it also means that HER2-positive treatments have a better chance of being effective.
Normal Cell
- Contains a normal number of HER2 receptors on its surface.
- The HER2 gene in the nucleus is present but not overactive.
- Cell growth signals are regulated and controlled.
- These cells grow and divide in a regular pattern.
HER2+ Cell (Breast Cancer Cell)
- Has too many HER2 receptors on its surface.
- The HER2 gene is overexpressed, resulting in an excess of HER2 protein.
- This results in overactive signaling for cell growth and division.
- Causes cells to multiply uncontrollably, leading to the formation of tumors.
What Is HER2-Positive Breast Cancer?
Definition and Prevalence
It’s a type of breast cancer where the cancer cells have too many HER2 receptors, which causes the cells to grow faster. About 15–20% of all breast cancers fall into this group.
This term used to signify a poor prognosis, but new treatments that target HER2 have significantly improved outcomes for patients.
HER2-Positive Cancer Characteristics
Some key traits of HER2-positive breast cancer:
- Fast-growing and aggressive
- Higher likelihood of metastasis
- Often found in hormone receptor-positive breast cancer.
- It can also overlap with triple-negative breast cancer, though less commonly.
If you’ve wondered how fast HER2-positive breast cancer spreads, the answer is: more rapid than many other subtypes, particularly when untreated.
How HER2 Status Is Diagnosed
Standard HER2 Testing Methods
Accurately determining your HER2 status is crucial for developing an effective treatment plan. This is typically done through:
- Immunohistochemistry (IHC): A staining process that measures how much HER2 protein is present. A score of 3+ means HER2-positive, while 0–1+ is HER2-negative breast cancer. A 2+ result is considered borderline.
- Fluorescence In Situ Hybridization (FISH): This test detects gene amplification and is used when IHC results are inconclusive.
These tests help oncologists determine whether HER2-positive treatment is appropriate or if alternative routes, such as HER2-negative treatment, should be considered.
HER2-Low Testing and Emerging Criteria
Doctors have started talking about a new group: HER2-low breast cancer. These cancers score 1+ or 2+ on IHC tests but come up negative on FISH tests. We used to think these were HER2-negative, but new research suggests they might respond to newer drugs, such as trastuzumab deruxtecan.
This has changed how we look at breast cancer care.
HER2-Positive Breast Cancer Treatment Options
Targeted Therapy Overview
Treatment options for HER2-positive breast cancer have advanced significantly due to targeted therapies. These drugs attack the HER2 protein directly:
- Trastuzumab (Herceptin) blocks HER2 and helps the immune system destroy cancer cells.
- Tukysa Tucatinib – used in combination with trastuzumab, a HER2-targeting antibody
- Pertuzumab – works with trastuzumab to block cell growth signals.
- Trastuzumab deruxtecan (Enhertu) – especially useful in HER2-low breast cancer and metastatic breast cancer.
These medications have extended survival rates and improved quality of life for thousands of patients globally.
Combination Treatments
HER2-positive treatment often includes combinations of:
- Targeted therapy
- Chemotherapy
- Hormonal therapy if the cancer is hormone receptor-positive
- Sometimes immunotherapy is used for complex or resistant cases.
Treatment Side Effects
Despite their effectiveness, these treatments carry some side effects:
- Heart toxicity (especially with trastuzumab)
- Nausea and fatigue
- Low blood counts
- Infusion reactions
Regular monitoring of heart function is critical during HER2 testing and ongoing treatment.
HER2-Negative Breast Cancer: A Different Path
What HER2-Negative Means
If your tests show you don’t have too much HER2 protein, you have HER2-negative breast cancer. These cancers don’t respond to drugs that target HER2, so they need different treatment. HER2-negative cancers can be:
- Hormone receptor-positive breast cancer (ER/PR+)
- Triple-negative breast cancer, which lacks estrogen, progesterone, and HER2 receptors
HER2-Low Breast Cancer: Bridging a New Category
What Is HER2-Low?
HER2-low breast cancer means tumors have low HER2 expression. It’s enough to set them apart from HER2-negative, but not enough to count as HER2-positive.
This new grouping is changing how doctors plan treatment for cases that are spread out.
New Treatment Advances for HER2-Low
The medicine trastuzumab deruxtecan works well for HER2-low breast cancer. It’s helpful for patients whose cancer has spread. This makes the old lines less clear and gives new hope to patients who didn’t have many choices before.
Metastasis and HER2 Status
How HER2-Positive Affects Spread
HER2-positive breast cancer tends to metastasize more quickly than HER2-negative. Common sites include:
- Liver
- Lungs
- Brain
- Bones
If you’re wondering how fast HER2-positive breast cancer spreads, studies suggest it can spread within months if left untreated
Symptoms and Monitoring
Watch for signs like:
- Persistent fatigue
- Bone pain
- Neurological symptoms
- Cough or difficulty breathing.
In metastatic breast cancer, routine imaging (PET/CT, MRI) and biomarker testing help track disease progression and treatment response.
Lifestyle Support for HER2-Positive Patients
Diet and Wellness Tips
No diet can cure cancer, but eating well can help during treatment. Here are some food tips for both HER2-negative, spread-out breast cancer and HER2-positive types:
- Eat more plant-based foods, whole grains, and lean proteins
- Limit processed foods and red meats.
- Stay hydrated and avoid excessive sugar.
- Reduce alcohol consumption
These habits can aid recovery, improve immune function, and support ongoing treatments.
Emotional and Mental Health Resources
Navigating a breast cancer diagnosis is emotionally taxing. Consider:
- Joining support groups
- Engaging in counseling or therapy
- Involving your family in treatment decisions
- Practicing mindfulness and stress-reducing techniques
Strong mental health is a powerful ally during cancer treatment.
Final Thoughts: Why Knowing Your HER2 Status Matters for Your Health
Understanding if your breast cancer is HER2-positive, HER2-negative, or HER2-low plays a key role in figuring out the best way to treat it. We now have more advanced and targeted treatment options than ever.
If you or someone close to you has this diagnosis, push for clear testing, think about the differences between HER2-positive and HER2-negative, and look into all the ways to treat HER2-positive cancer to make sure you get the best results.
References
Mayo Clinic – HER2-positive breast cancer – Click here
WebMD – HER2-Positive Overview – Click here
NCBI – HER2 Research – Click here
Drugs.com – HER2-targeted therapies – Click here
PubMed – HER2-Low and HER2-Negative Studies – Click here
MedlinePlus – HER2 Testing – Click here
Medscape – Trastuzumab Updates – Click here
Medical News Today – HR-Positive, HER2-Negative Treatment Click here
Cleveland Clinic – HER2 Metastatic Breast Cancer Community Click here